Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |